scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.VACCINE.2018.06.021 |
P698 | PubMed publication ID | 29941327 |
P50 | author | Julia Drylewicz | Q56809902 |
Marije P Hennus | Q114258327 | ||
Louis J Bont | Q114259431 | ||
P2093 | author name string | Cornelis K van der Ent | |
José A M Borghans | |||
Kentigern Thorburn | |||
Nienke M Scheltema | |||
Job B van Woensel | |||
Xynthia M Kavelaars | |||
P2860 | cites work | Risk factors for respiratory syncytial virus associated with acute lower respiratory infection in children under five years: Systematic review and meta-analysis | Q26774885 |
Maternal immunization | Q26853746 | ||
IgG placental transfer in healthy and pathological pregnancies | Q27025979 | ||
The level and duration of RSV-specific maternal IgG in infants in Kilifi Kenya | Q30941156 | ||
The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity | Q33574734 | ||
Pertussis Antibody Transfer to Preterm Neonates After Second- Versus Third-Trimester Maternal Immunization | Q33712033 | ||
Defining the vaccination window for respiratory syncytial virus (RSV) using age-seroprevalence data for children in Kilifi, Kenya. | Q33712986 | ||
The burden of respiratory syncytial virus infection in young children | Q34938343 | ||
Respiratory syncytial virus-associated intensive care unit admission in children in Southern China | Q35037404 | ||
Respiratory syncytial virus transplacental antibody transfer and kinetics in mother-infant pairs in Bangladesh | Q35102554 | ||
Lower transplacental antibody transport for measles, mumps, rubella and varicella zoster in very preterm infants | Q35146973 | ||
Quantifying maternally derived respiratory syncytial virus specific neutralising antibodies in a birth cohort from coastal Kenya | Q35223733 | ||
Efficacy and optimization of palivizumab injection regimens against respiratory syncytial virus infection | Q35347139 | ||
Mortality in children from influenza and respiratory syncytial virus | Q35559491 | ||
Absence of Association between Cord Specific Antibody Levels and Severe Respiratory Syncytial Virus (RSV) Disease in Early Infants: A Case Control Study from Coastal Kenya | Q36194104 | ||
Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction. | Q37410332 | ||
Fatality rates in published reports of RSV hospitalizations among high-risk and otherwise healthy children | Q37776266 | ||
Transplacental transport of IgG antibodies to preterm infants: a review of the literature | Q37814668 | ||
Duration of Infant Protection Against Influenza Illness Conferred by Maternal Immunization: Secondary Analysis of a Randomized Clinical Trial | Q38390492 | ||
Hospitalisation of preterm infants with pertussis in the context of a maternal vaccination programme in England | Q38621552 | ||
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study | Q38687853 | ||
Pertussis and influenza immunisation during pregnancy: a landscape review | Q38691984 | ||
Intensive Care Unit Admission and Death Rates of Infants Admitted With Respiratory Syncytial Virus Lower Respiratory Tract Infection in Mexico | Q39700756 | ||
Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series | Q40040542 | ||
Transplacental transfer of maternal respiratory syncytial virus (RSV) antibody and protection against RSV disease in infants in rural Nepal | Q40043300 | ||
Maternal pertussis and influenza immunization coverage and attitude of health care workers towards these recommendations in Flanders, Belgium | Q40485629 | ||
Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women | Q40555244 | ||
A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age. | Q41060727 | ||
Modeling maternal fetal RSV F vaccine induced antibody transfer in guinea pigs | Q41441320 | ||
Potential impact of a maternal vaccine for RSV: A mathematical modelling study. | Q41926872 | ||
WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23-24 March 2015. | Q45341636 | ||
Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection | Q45392619 | ||
The role of neutralizing antibodies in protection of American Indian infants against respiratory syncytial virus disease | Q45397091 | ||
Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997. | Q45739727 | ||
Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus | Q45759631 | ||
The effect of timing of maternal tetanus, diphtheria, and acellular pertussis (Tdap) immunization during pregnancy on newborn pertussis antibody levels - a prospective study. | Q53084808 | ||
Kinetics of the Antibody Response to Tetanus-Diphtheria-Acellular Pertussis Vaccine in Women of Childbearing Age and Postpartum Women | Q57793146 | ||
Evolution of maternofetal transport of immunoglobulins during human pregnancy | Q71860864 | ||
P433 | issue | 31 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | infancy stage | Q49257364 |
P304 | page(s) | 4693-4700 | |
P577 | publication date | 2018-06-22 | |
P1433 | published in | Vaccine | Q7907941 |
P1476 | title | Potential impact of maternal vaccination on life-threatening respiratory syncytial virus infection during infancy | |
P478 | volume | 36 |